Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Timing bond allocations can reduce risk and stabilize income in retirement. Learn indicators and phased approaches to use bonds effectively.
22,161 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Oklo has faced a challenging six months as the stock trended lower with little revenue to show. This article explores...
A breakthrough with Iran aims to reopen the Strait of Hormuz, but experts say it will take months for supplies to nor...
The EU’s MiCA deadline looms, challenging crypto platforms to win licenses or lose EU access. Binance’s Greece strate...
A new tech-specific volatility metric is approaching its highest level in two decades, underscoring rising nerves aro...
Tower Semiconductor faced a notable drop as AI-driven demand and profitability questions swirl. This guide breaks dow...
US spot Bitcoin ETFs posted another day of outflows on June 30, extending a nine-day streak and signaling a broader c...
Strategy reported a dramatic second quarter loss tied to its Bitcoin holdings, even as the company bought more BTC ov...
SBI Holdings has led a $125 million Series C round for Tarun Chitra’s Gauntlet, the DeFi risk analytics platform. The...
Berkshire Hathaway faces a pivotal July 22 shareholder vote on a major housing bet. This deep dive explains what’s at...
A major biotech acquisition news drove a sharp move in ATAI shares. This article breaks down why ataibeckley stock so...
This article dives into why this dividend stock's moat offers unparalleled stability for long-term investors. Discove...